Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Accumulated Depreciation (2020 - 2026)

Maxcyte has reported Accumulated Depreciation over the past 6 years, most recently at $17.3 million for Q4 2025.

  • Quarterly Accumulated Depreciation rose 27.02% to $17.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.3 million through Dec 2025, up 27.02% year-over-year, with the annual reading at $17.3 million for FY2025, 27.02% up from the prior year.
  • Accumulated Depreciation was $17.3 million for Q4 2025 at Maxcyte, up from $17.0 million in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $17.3 million in Q4 2025 and troughed at $3.6 million in Q2 2021.
  • The 5-year median for Accumulated Depreciation is $9.3 million (2023), against an average of $9.7 million.
  • Year-over-year, Accumulated Depreciation soared 65.6% in 2023 and then grew 27.02% in 2025.
  • A 5-year view of Accumulated Depreciation shows it stood at $4.4 million in 2021, then skyrocketed by 43.51% to $6.3 million in 2022, then soared by 63.92% to $10.3 million in 2023, then surged by 32.14% to $13.6 million in 2024, then rose by 27.02% to $17.3 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Accumulated Depreciation are $17.3 million (Q4 2025), $17.0 million (Q3 2025), and $16.5 million (Q2 2025).